Issue link: https://maltatoday.uberflip.com/i/1442703
13.1.2022 6 MARKETS Symbol Volume Value Trades High Low Open Closing Change Code Traded Traded Trades Price Price Price Price EQUITIES BMIT 22,500 10,801.00 2 0.482 0.480 0.480 0.482 -0.004 BOV 10,100 8,596.00 4 0.860 0.850 0.860 0.850 -0.010 GO 28 91.28 1 3.260 3.260 3.260 3.260 0.000 HLI 50,000 13,570.00 3 0.272 0.270 0.270 0.272 -0.002 HSB 12,000 10,997.27 2 0.920 0.915 0.915 0.920 0.045 MIA 7,605 44,109.00 3 5.800 5.800 5.800 5.800 -0.050 MTP 5,080 6,096.00 1 1.200 1.200 1.200 1.200 -0.020 PG 2,000 4,760.00 1 2.380 2.380 2.380 2.380 -0.020 SFC 1,212 9,877.80 3 8.150 8.150 8.150 8.150 -0.350 GOVERNMENT STOCKS G28B 9,000 11,421.00 1 126.900 126.900 126.900 126.900 -0.210 G30A 550,000 758,845.00 2 138.000 137.690 138.000 137.690 -0.350 G36A 3,000 3,483.60 1 116.120 116.120 116.120 116.120 -1.030 G51A 50,000 51,750.00 1 103.500 103.500 103.500 103.500 -0.400 CORPORATE BONDS BX27A 5,000 5,075.50 1 101.510 101.510 101.510 101.510 0.010 CB33A 18,100 18,353.40 2 101.400 101.400 101.400 101.400 0.150 DN33A 20,000 20,600.00 4 103.000 103.000 103.000 103.000 0.000 EF27A 2,000 2,000.00 1 100.000 100.000 100.000 100.000 -1.000 GO31A 30,000 30,897.27 4 103.000 102.990 102.990 103.000 0.000 HF28A 6,000 6,000.00 1 100.000 100.000 100.000 100.000 0.000 HF29A 3,000 3,000.00 1 100.000 100.000 100.000 100.000 -0.500 IH25A 7,300 7,482.50 1 102.500 102.500 102.500 102.500 0.000 IH26A 43,500 43,627.43 4 101.990 100.000 100.500 100.000 0.000 MO31A 8,100 8,293.59 1 102.390 102.390 102.390 102.390 -0.010 MY27A 5,000 5,000.50 1 100.010 100.010 100.010 100.010 0.000 ST27A 15,000 15,450.00 2 103.000 103.000 103.000 103.000 -0.500 VH24A 10,000 9,999.00 2 99.990 99.990 99.990 99.990 -0.940 Malta Stock Exchange Reguated Main Market Trading Date: 12 January 2022 EU drug watchdog doubts need for fourth COVID-19 vaccine dose THE European Medicines Agen- cy (EMA) has expressed doubts about giving the general popula- tion a fourth COVID-19 vaccine shot, saying repeated boosters are not a "sustainable" strategy. e EMA also said the spread of the Omicron variant of coro- navirus is pushing COVID-19 to- wards being an endemic disease. "While use of additional boost- ers can be part of contingency plans, repeated vaccinations within short intervals would not represent a sustainable long- term strategy," the EMA's head of vaccines strategy, Marco Cav- aleri, told a media briefing. He raised concerns that repeat- ed boosters could overload peo- ple's immune systems. "If we have a strategy in which we give boosters every four months, we will end up poten- tially having problems with im- mune response," the EMA offi- cial said. "And secondly of course there is the risk of fatigue in the popu- lation with continuous adminis- tration of boosters." Countries should instead start thinking about spacing out boosters at longer intervals, and, like flu jabs, synchronise them with the start of the cold season, Cavaleri said. "With the increase of immuni- ty in population - and with Omi- cron, there will be a lot of nat- ural immunity taking place on top of vaccination - we will be fast moving towards a scenario that will be closer to endemicity," he added, but stressed that "we should not forget we are still in a pandemic". The World Health Organiza- tion said on Tuesday that more than half of people in Europe were on track to catch the Omi- cron variant in the next two months. WHO also warned that repeat- ed COVID-19 boosters were not a viable strategy. "While use of additional boosters can be part of contingency plans, repeated vaccinations within short intervals would not represent a sustainable long-term strategy," said EMA official Marco Cavaleri RS2 PLC PREF